Company: PIII
Filing Date: 2025-04-18
Form Type: PRE 14A
Source: 0001140361-25-014596
Chunk: 25

Company: P3 Health Partners Inc.
Filing Date: 2025-04-18
Form: PRE 14A
Chunk 25
---
 the aggregate principal amount of the loans advanced to P3 LLC on or prior to such date; (iii) if repaid from July 1, 2025 through September 30, 2025, 6.75% of the aggregate principal amount of the loans advanced to P3 LLC on or prior to such date; and (iv) if repaid on October 1, 2025 or later, 9.0% of the aggregate principal amount of the loans advanced to P3 LLC on or prior to such date. VBC 4 Warrants In connection with the Promissory Note, on February 13, 2025, we, P3 LLC and VBC 4 entered into a Warrant Agreement (the “Warrant Agreement”). Pursuant to the Warrant Agreement, P3 LLC issued the VBC 4 Warrants to VBC 4 to purchase 1,428,129 shares of our Class A common stock, at an exercise price of $[ ] per share (as adjusted for the Reverse Stock Split). Each VBC 4 Warrant will be exercisable only following stockholder approval of the issuance of the shares of Common Stock underlying the VBC 4 Warrants pursuant to Nasdaq Listing Rule 5635(d). We have agreed to use our reasonable best efforts to obtain such stockholder approval at this Annual Meeting. If we do not obtain such stockholder approval at this Annual Meeting, we have agreed to call up to three special meetings of our stockholders every six months thereafter (which may also be an annual meeting of stockholders) to seek such stockholder approval until the earliest of (x) the date such stockholder approval is obtained and (y) December 31, 2026. The VBC 4 Warrants provide that VBC 4 shall not be entitled to exercise the VBC 4 Warrant for a number of shares in excess of that number which, upon giving effect to such exercise, would result in (i) the aggregate number of shares beneficially owned by VBC 4, its affiliates and any other persons whose beneficial ownership of Common Stock would be aggregated with VBC 4’s for purposes of Section 13(d) of the Exchange Act exceeding 49.99% of the total number of issued and outstanding shares of Common Stock following such exercise, or (ii) the combined voting power of our securities beneficially owned by VBC 4, its affiliates and any other persons whose beneficial ownership of Common Stock would be aggregated